599
Views
32
CrossRef citations to date
0
Altmetric
Reviews

Mechanisms underlying methotrexate-induced pulmonary toxicity

, &
Pages 451-458 | Published online: 21 Jun 2009

Bibliography

  • Rosenow EC. Drug-induced pulmonary disease. Dis Mon 1994;40:253-310
  • Genestier L, Paillot R, Quemeneur L, et al. Mechanisms of action of methotrexate. Immunopharmacology 2000;47(2-3):247-57
  • Linnebank M, Moskau S, Jürgens A, et al. Association of genetic variants of methionine matabolism with methotrexate-induced CNS white matter changes in patients with primary CNS lymphoma.Neuro Oncol 2009;11:2-8
  • Swierkot J, Szechinski J. Methotrexate in rheumatoid arthritis. Pharmacol Rep 2006;58:473-92
  • Weisman MH, Furst DE, Park GS, et al. Risk genotypes in folate-dependent enzymes and their association with methotrexate-related side effects in rheumatoid arthritis. Arthritis Rheum 2006;54:607-12
  • StClair EW, van der Heijide DM, Smolen JS, et al. Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial. Arthritis Rheum 2004;50:3432-43
  • Kremer JM, Alarcón GS, Weinblatt ME, et al. Clinical, laboratory, radiographic, and histopathologic features of methotrexate-associated lung injury in patients with rheumatoid arthritis: a multicenter study with literature review. Arthritis Rheum 1997;40:1829-37
  • Yamauchi Y, Okazaki H, Desaki M., et al. Methotrexate induces interleukin-8 production by human bronchial and alveolar epithelial cells. Clin Sci 2004;106:619-25
  • Hsu PC, Lan JL, Hsieh TY, et al. Methotrexate pneumonitis in a patient with rheumatoid arthritis. J Microbiol Immunol Infect 2003;36:137-40
  • Chikura B, Sathi N, Lane S, et al. Variation of immunological response in methotrexate-induced pneumonitis. Rheumatology 2008;47(11):1647-50
  • Thavarajah K, Wu P, Rhew EJ, et al. Pulmonary complications of tumor necrosis factor-targeted therapy. Respir Med 2009;103(5):661-9
  • Mornex JF, Cordier G, Pages J, et al. Activated lung lymphocytes in hypersensitivity pneumonitis. J Allergy Clin Immunol 1984;74(5):719-27
  • Akoun GM, Gauthier-Rahman S, Mayaud CM, et al. Leukocyte migration inhibition in methotrexate-induced pneumonitis. Evidence for an immunologic cell-mediated mechanism. Chest 1987;91(1):96-9
  • Schnabel A, Richter C, Bauerfeind S, et al. Bronchoalveolar lavage cell profile in methotrexate induced pneumonitis. Thorax 1997;52(4):377-9
  • Enelow RI, Mohammed AZ, Stoler MH, et al. Structural and functional consequences of alveolar cell recognition by CD8(+) T lymphocytes in experimental lung disease. J Clin Invest 1998;102(9):1653-61
  • Fujimori Y, Kataoka M, Tada S, et al. The role of Interleukin-8 in interstitial pneumonia. Respirology 2003;8:33-40
  • Ziesche R, Hofbauer E, Wittmann K, et al. A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis. N Engl J Med 1999;341(17):1264-9
  • Selman M, King TE, Pardo A. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 2001;134(2):136-51
  • Obavashi Y, Yamadori I, Fujita J, et al. The role of neutrophils in the pathogenesis of idiopathic pulmonary fibrosis. Chest 1997;112(5):1338-43
  • Crestani B, Dehoux M, Hayem G, et al. Differential role of neutrophils and alveolar macrophages in hepatocyte growth factor production in pulmonary fibrosis. Lab Invest 2002;82(8):1015-22
  • Pardo A, Barrios R, Gaxiola M, et al. Increase of lung neutrophils in hypersensitivity pneumonitis is associated with lung fibrosis. Am J Respir Crit Care Med 2000;161(5):1698-704
  • Lin YH, Haslam PL, Turner-Warwick M. Chronic pulmonary sarcoidosis: relationship between lung lavage cell counts, chest radiograph, and results of standard lung function tests. Thorax 1985;40(7):501-7
  • Robbins RA, Jinkins PA, Bryan TW, et al. Methotrexate inhibition of inducible nitric oxide synthase in murine lung epithelial cells in vitro. Am J Respir Cell Mol Biol 1998;18(6):853-9
  • Daba MH, El-Tahir KE, Al-Arifi MN, et al. Drug-induced pulmonary fibrosis. Saudi Med J 2004;25(6):700-6
  • Schnabel A, Reinhold-Keller E, Willmann V, et al. Tolerability of methotrexate starting with 15 or 25 mg/week for rheumatoid arthritis. Rheumatol Int 1994;14(1):33-8
  • van Ede AE, Laan RF, Blom HJ, et al. Methotrexate in rheumatoid arthritis: an update with focus on mechanisms involved in toxicity. Semin Arthritis Rheum 1998;27(5):277-92
  • Goodman TA, Polisson RP. Methotrexate: adverse reactions and major toxicities. Rheum Dis Clin North Am 1994;20(2):513-28
  • Grosflam J, Weinblatt ME. Methotrexate: mechanism of action, pharmacokinetics, clinical indications, and toxicity. Curr Opin Rheumatol 1991;3(3):363-8
  • Kremer JM. Methotrexate update. Scand J Rheumatol 1996;25(6):341-4
  • Hirata S, Matsubara T, Saura R, et al. Inhibition of in vitro vascular endothelial cell proliferation and in vivo neovascularization by low-dose methotrexate. Arthritis Rheum 1989;32(9):1065-73
  • Merkle CJ, Moore IM, Penton BS, et al. Methotrexate causes apoptosis in postmitotic endothelial cells. Biol Res Nurs 2000;2(1):5-14
  • Olsen NJ, Murray LM. Antiproliferative effects of methotrexate on peripheral blood mononuclear cells. Arthritis Rheum 1989;32(4):378-85
  • Olsen NJ, Callahan LF, Pincus T. Immunologic studies of rheumatoid arthritis patients treated with methotrexate. Arthritis Rheu 1987;30(5):481-8
  • Nesher G, Moore TL. The in vitro effects of methotrexate on peripheral blood mononuclear cells. Modulation by methyl donors and spermidine. Arthritis Rheum 1990;33(7):954-9
  • Cronstein BN, Naime D, Ostad E. The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation. J Clin Invest 1993;92(6):2675-82
  • Phillips DC, Woollard KJ, Griffiths HR. The anti-inflammatory actions of methotrexate are critically dependent upon the production of reactive oxygen species. Br J Pharmacol 2003;138:501-11
  • Cronstein BN. Molecular therapeutics. Methotrexate and its mechanism of action. Arthritis Rheum 1996;39(12):1951-60
  • H Wolf RE, Granger DN. Leukocyte adherence in rat mesenteric venules: effects of adenosine and methotrexate. Gastroenterology 1993;104(1):31-7
  • Cronstein BN, Levin RI, Belanoff J, et al. Adenosine: an endogenous inhibitor of neutrophil-mediated injury to endothelial cells. J Clin Invest 1986;78(3):760-70
  • Cronstein BN, Rosenstein ED, Kramer SB, et al. Adenosine; a physiologic modulator of superoxide anion generation by human neutrophils. Adenosine acts via an A2 receptor on human neutrophils. J Immunol 1985;135(2):1366-71
  • Parmely MJ, Zhou WW, Edwards CK, et al. Adenosine and a related carbocyclic nucleoside analogue selectively inhibit tumor necrosis factor-alpha production and protect mice against endotoxin challenge. J Immunol 1993;151(1):389-96
  • Lappin D, Whaley K. Adenosine A2 receptors on human monocytes modulate C2 production. Clin Exp Immunol 1984;57(2):454-60
  • Ranganathan P, Eisen S, Yokoyama WM, et al. Will pharmacogenetics allow better prediction of methotrexate toxicity and efficacy in patients with rheumatoid arthritis? Ann Rheum Dis 2003;62(1):4-9
  • Banerjee D, Mayer-Kuckuk P, Capiaux G, et al. Novel aspects of resistance to drugs targeted to dihydrofolate reductase and thymidylate synthase. Biochim Biophys Acta 2002;1587(2-3):164-73
  • Stamp L, Roberts R, Kennedy M, et al. The use of low dose methotrexate in rheumatoid arthritis - are we entering a new era of therapeutic drug monitoring and pharmacogenomics? Biomed Pharmacother 2006;60(10):678-87
  • de Graaf D, Sharma RC, Mechetner EB, et al. P-glycoprotein confers methotrexate resistance in 3T6 cells with deficient carrier-mediated methotrexate uptake. Proc Natl Acad Sci USA 1996;93:1238-42
  • Yoshida S, Onuma K, Amayasu H, et al. Elevated levels of IL-8 in interstitial pneumonia induced by low-dose methotrexate. J Allergy Clin Immunol 1999;103:952-4
  • Yoshimura T, Matsushima K, Oppenheim JJ, et al. Neutrophil chemotactic factor produced by lipopolysaccharide (LPS)-stimulated human blood mononuclear leukocytes: partial characterization and separation from interleukin-1 (IL1). J Immunol 1987;39:788-93
  • Standiford TJ, Kunkel SL, Basha MA, et al. Interleukin-8 gene expression by a pulmonary epithelial cell line. A model for cytokine networks in the lung. J Clin Invest 1999;86:1945-53
  • Nakagami H, Pitzschke A, Hirt H. Emerging MAP kinase pathways in plant stress signalling. Trends Plant Sci 2005;10(7):339-46
  • Johnson GL, Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 2002;298:1911-2
  • Ge B, Xiong X, Jing Q, et al. TAB1beta (transforming growth factor-beta-activated protein kinase 1-binding protein 1beta), a novel splicing variant of TAB1 that interacts with p38alpha but not TAK1. J Biol Chem 2003;278:2286-93
  • Kim YJ, Song M, Ryu JC. Inflammation in methotrexate-induced pulmonary toxicity occurs via the p38 MAPK pathway. Toxicology 2009;256(3):183-90
  • Holtmann H, Enninga J, Kalble S, et al. The MAPK kinase kinase TAK1 plays a central role in coupling the interleukin-1 receptor to both transcriptional and RNA-targeted mechanisms of gene regulation. J Biol Chem 2001;276:3508-16
  • Choo MK, Sakurai H, Koizumi K, et al. TAK1-mediated stress signaling pathways are essential for TNF-alpha-promoted pulmonary metastasis of murine colon cancer cells. Int J Cancer 2006;118:2758-64
  • Alford KA, Glennie S, Turrell BR, et al. Heat shock protein 27 functions in inflammatory gene expression and transforming growth factor-beta-activated kinase-1 (TAK1)-mediated signaling. J Biol Chem 2007;282:6232-41
  • Kim AL, Labasi JM, Zhu Y, et al. Role of p38 MAPK in UVB-induced inflammatory responses in the skin of SKH-1 hairless mice. J Invest Dermatol 2005;124:1318-25
  • Ridley SH, Sarsfield SJ, Lee JC, et al. Actions of IL-1 are selectively controlled by p38 mitogen-activated protein kinase: regulation of prostaglandin H synthase-2, metalloproteinases, and IL-6 at different levels. J Immunol 1997;158(7):3165-73
  • Yang J, Hooper WC, Phillips DJ, et al. Regulation of proinflammatory cytokines in human lung epithelial cells infected with Mycoplasma pneumoniae. Infect Immun 2002;70:3649-55
  • Auron PE, Warner SJ, Webb AC, et al. Studies on the molecular nature of human interleukin 1. J Immunol 1987;138:1447-56
  • Nagaoka I, Trapnell BC, Crystal RG. Upregulation of platelet-derived growth factor-A and -B gene expression in alveolar macrophage of individuals with idiopathic pulmonary fibrosis. J Clin Invest 1990;85:2023-7
  • Broekelmann TJ, Limper AH, Colby TV, et al. Transforming growth factor beta 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc Natl Acad Sci USA 1991;88:6642-6
  • Nagai S, Aung H, Takeuchi M, et al. IL-1 and IL-1 inhibitory activity in the culture supernatants of alveolar macrophages from patients with interstitial lung diseases. Chest 1991;99:674-80
  • Lynch JP, Standiford TJ, Rolphe MW, et al. Neutrophilic alveolitis in idiopathic pulmonary fibrosis. The role of interleukin-8. Am Rev Respir Dis 1992;145:1433-9
  • Zhang Y, Lee TC, Guillemin B, et al. Enhanced IL-1 beta and tumor necrosis factor-alpha release and messenger RNA expression in macrophages from idiopathic pulmonary fibrosis or after asbestos exposure. J Immunol 1993;150:4188-96
  • Iyonaga K, Takeya M, Saita N, et al. Monocyte chemoattractant protein-1 in idiopathic pulmonary fibrosis and other interstitial lung diseases. Hum Pathol 1994;25:455-63
  • Gerards AH, Lathouder S, Groot ER, et al. Inhibition of cytokine production by methotrexate. Studies in healthy volunteers and patients with rheumatoid arthritis. Rheumatology 2003;42:1189-96
  • Sarma NS, Kim YJ, Ryu JC. Differential gene expression profiling in human promyelocytic leukemia cells treated with benzene and ethylbenzene. Mol Cell Toxicol 2008;4(4):267-77
  • Kim YJ, Song MK, Sarma NS, et al. Functional gene analysis to identify potential markers induced by benzene in two different cell lines, HepG2 and HL-60. Mol Cell Toxicol 2008;4(3):183-91
  • Ashburner M, Ball CA, Blake JA, et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 2000;25(1):25-9
  • Kushida T, Takagi T, Fukuda KI. Event ontology: a pathway-centric ontology for biological processes. Pac Symp Biocomput 2006;152-63
  • Te Pas MF, Hulsegge I, Coster A, et al. Biochemical pathways analysis of microarray results: regulation of myogenesis in pigs. BMC Dev Biol 2007;7:66

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.